Log in to save to my catalogue

Midkine promotes breast cancer cell proliferation and migration by upregulating NR3C1 expression and...

Midkine promotes breast cancer cell proliferation and migration by upregulating NR3C1 expression and...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2620080985

Midkine promotes breast cancer cell proliferation and migration by upregulating NR3C1 expression and activating the NF-κB pathway

About this item

Full title

Midkine promotes breast cancer cell proliferation and migration by upregulating NR3C1 expression and activating the NF-κB pathway

Publisher

Dordrecht: Springer Netherlands

Journal title

Molecular biology reports, 2022-04, Vol.49 (4), p.2953-2961

Language

English

Formats

Publication information

Publisher

Dordrecht: Springer Netherlands

More information

Scope and Contents

Contents

Background
Breast cancer (BC) is the most common malignancy in females and is the second leading cause of cancer-related death among women worldwide. Midkine (MDK) is a heparin-binding growth factor that is abnormally expressed at high levels in various human malignancies. We aimed to uncover the biological function and molecular mechanism of MD...

Alternative Titles

Full title

Midkine promotes breast cancer cell proliferation and migration by upregulating NR3C1 expression and activating the NF-κB pathway

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_2620080985

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2620080985

Other Identifiers

ISSN

0301-4851

E-ISSN

1573-4978

DOI

10.1007/s11033-022-07116-7

How to access this item